Actively Recruiting
DeMONSTRATE-TB Study in Ethiopia
Led by Management Sciences for Health · Updated on 2024-12-05
131438
Participants Needed
2
Research Sites
96 weeks
Total Duration
On this page
Sponsors
M
Management Sciences for Health
Lead Sponsor
K
KNCV Tuberculosis Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Ending the TB epidemic by 2035 in Ethiopia would be possible if TB notification declines by an annual factor of at least 15% from the current notification rate of 132 per 100,000 population. This requires highly effective strategies to reduce TB transmission and maximize TB prevention among populations at risk of developing TB, such as Household contacts and people living with HIV. The investigators hypothesize that community wide administration of enhanced TPT will accelerate decline in TB incidence rates when combined with an optimized currently recommended comprehensive TB prevention and care packages described below. The investigators further hypothesize that such intervention packages will be acceptable to the community, providers and policy makers, and that they will be cost-effective. Based on the study results, a TB elimination framework in high burden TB regions and woredas in Ethiopia will be developed, and local evidence to enhance the shift toward TB elimination will be provided as input to the appropriate allocation of resources.
CONDITIONS
Official Title
DeMONSTRATE-TB Study in Ethiopia
Who Can Participate
Eligibility Criteria
You may qualify if you...
-
Adults:
- Greater than or equal to 18 years old
- Provides consent
- Living in study site area (woreda)
-
Children
- Aged 12 to 17 years
- Living in the study site area (woreda)
- Assent to enrollment
- Guardian provides consent for enrollment
-
Younger children:
- Less than 12 years old
- Living in the study site area (woreda)
- Consent for enrollment provided by the guardian
You will not qualify if you...
-
Adults:
- Does not provide consent
- Declines to provide contact information
- Less than 18 years
- Living outside of the study site area
- Declines to allow study staff to contact them by phone and in person if they miss a study visit
-
Children
- Does not provide assent
- Guardian does not provide consent
- Guardian declines to provide contact information
- Not within 12 to 17 years
- Living outside of the study site area
- Guardian declines to allow study staff to contact them by phone and in person if they miss a study visit
-
Younger Children
- Guardian does not provide consent
- Guardian declines to provide contact information
- Not less than 12 years
- Living outside of the study site area
- Guardian declines to allow study staff to contact them by phone and in person if they miss a study visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Gedebe Hassassa woreda
West Arsi Zone, Ormoia Regional State, Ethiopia
Actively Recruiting
2
Boloso Bombe woreda
Wolayita Zone, South Ethiopia Regional State, Ethiopia
Actively Recruiting
Research Team
O
Oumer Ali, PhD
CONTACT
Z
Zewdu Dememew, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here